Literature DB >> 17228253

Risk of malignancy after gamma knife stereotactic radiosurgery.

Jeremy Rowe1, Alison Grainger, Lee Walton, Paul Silcocks, Matthias Radatz, Andras Kemeny.   

Abstract

OBJECTIVE: To assess the risk of radiosurgery to cause malignant transformation in benign tumors or to induce new malignancies.
METHODS: A retrospective cohort study comparing the Sheffield, England, radiosurgery patient database with national mortality and cancer registries. This data set comprises approximately 5000 patients and 30,000 patient-years of follow-up, with more than 1200 patients having a follow-up period longer than 10 years.
RESULTS: In this material, a single new astrocytoma was diagnosed, whereas, based on national incidence figures, 2.47 cases would have been predicted.
CONCLUSION: No increased risk of malignancy was detected in this series, supporting the safety of radiosurgery. Pragmatically, in advising patients, the risks of malignancy would seem small, particularly if such risks are considered in the context of the other risks faced by patients with intracranial pathologies requiring radiosurgical treatments.

Entities:  

Mesh:

Year:  2007        PMID: 17228253     DOI: 10.1227/01.NEU.0000255492.34063.32

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  32 in total

Review 1.  Role of stereotactic radiosurgery in the management of pituitary adenomas.

Authors:  Frederic Castinetti; Jean Régis; Henry Dufour; Thierry Brue
Journal:  Nat Rev Endocrinol       Date:  2010-02-23       Impact factor: 43.330

Review 2.  Stereotactic radiosurgery of benign intracranial tumors.

Authors:  Bruce E Pollock
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

3.  [No evidence for radiation-induced tumors after intracranial radiosurgery].

Authors:  Clemens Seidel; Rolf-Dieter Kortmann
Journal:  Strahlenther Onkol       Date:  2017-09       Impact factor: 3.621

Review 4.  Management of aggressive growth hormone secreting pituitary adenomas.

Authors:  Daniel A Donoho; Namrata Bose; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 5.  Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.

Authors:  Stephanie R McKeown; Paul Hatfield; Robin J D Prestwich; Richard E Shaffer; Roger E Taylor
Journal:  Br J Radiol       Date:  2015-10-14       Impact factor: 3.039

Review 6.  Unyielding progress: recent advances in the treatment of central nervous system neoplasms with radiosurgery and radiation therapy.

Authors:  Dale Ding; Chun-Po Yen; Robert M Starke; Cheng-Chia Lee; Jason P Sheehan
Journal:  J Neurooncol       Date:  2014-08-14       Impact factor: 4.130

Review 7.  Stereotactic radiosurgery for WHO grade I meningiomas.

Authors:  Jason P Sheehan; Brian J Williams; Chun Po Yen
Journal:  J Neurooncol       Date:  2010-08-24       Impact factor: 4.130

8.  Malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery.

Authors:  Andreas K Demetriades; Nicholas Saunders; Peter Rose; Cyril Fisher; Jeremy Rowe; Robert Tranter; Carl Hardwidge
Journal:  Skull Base       Date:  2010-09

9.  Surgical management of vestibular schwannomas after failed radiation treatment.

Authors:  Yoichi Nonaka; Takanori Fukushima; Kentaro Watanabe; Allan H Friedman; Calhoun D Cunningham; Ali R Zomorodi
Journal:  Neurosurg Rev       Date:  2016-01-19       Impact factor: 3.042

10.  Malignization of a vestibular schwannoma 13 years after radiation therapy.

Authors:  S Simmermacher; D Vordermark; T Kegel; C Strauss
Journal:  HNO       Date:  2017-08       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.